
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ren Fail</journal-id><journal-id journal-id-type="iso-abbrev">Ren Fail</journal-id><journal-title-group><journal-title>Renal Failure</journal-title></journal-title-group><issn pub-type="ppub">0886-022X</issn><issn pub-type="epub">1525-6049</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32954910</article-id><article-id pub-id-type="pmc">7534388</article-id><article-id pub-id-type="doi">10.1080/0886022X.2020.1818580</article-id><article-id pub-id-type="publisher-id">1818580</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of
Record</article-version><article-categories><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Laboratory Study</subject></subj-group></article-categories><title-group><article-title>Protective effect of curcumin on busulfan-induced renal toxicity in male
rats</article-title><alt-title alt-title-type="left-running-head">M.-A. Abdollahifar et al.</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Abdollahifar</surname><given-names>Mohammad-Amin</given-names></name><xref ref-type="aff" rid="AF0001">a</xref></contrib><contrib contrib-type="author"><name><surname>Ebrahimi</surname><given-names>Vahid</given-names></name><xref ref-type="aff" rid="AF0002">b</xref></contrib><contrib contrib-type="author"><name><surname>Aliaghaei</surname><given-names>Abbas</given-names></name><xref ref-type="aff" rid="AF0001">a</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7402-1726</contrib-id><name><surname>Raoofi</surname><given-names>Amir</given-names></name><xref ref-type="aff" rid="AF0003">c</xref></contrib><contrib contrib-type="author"><name><surname>Khosravi</surname><given-names>Amirreza</given-names></name><xref ref-type="aff" rid="AF0001">a</xref></contrib><contrib contrib-type="author"><name><surname>Hasani</surname><given-names>Amirhosein</given-names></name><xref ref-type="aff" rid="AF0001">a</xref></contrib><contrib contrib-type="author"><name><surname>Mehdizadeh</surname><given-names>Ali</given-names></name><xref ref-type="aff" rid="AF0004">d</xref><xref ref-type="corresp" rid="AN0001"/></contrib><contrib contrib-type="author"><name><surname>Asadi</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="AF0004">d</xref><xref ref-type="corresp" rid="AN0002"/></contrib><aff id="AF0001"><label>a</label><institution>Department of Biology and Anatomical Sciences,
School of Medicine, Shahid Beheshti University of Medical Sciences</institution>,
<city>Tehran</city>, <country>Iran</country></aff><aff id="AF0002"><label>b</label><institution>Department of Anatomy and Cell Biology, School
of Medicine, Mashhad University of Medical Sciences</institution>, <city>Mashhad</city>,
<country>Iran</country></aff><aff id="AF0003"><label>c</label><institution>Leishmaniasis Research Center, Department of
Anatomy, Sabzevar University of Medical Sciences</institution>, <city>Sabzevar</city>,
<country>Iran</country></aff><aff id="AF0004"><label>d</label><institution>Student Research Committee, Department and
Faculty of Medical Sciences, Shahid Beheshti University of Medical
Sciences</institution>, <city>Tehran</city>, <country>Iran</country></aff></contrib-group><author-notes><corresp id="AN0001">CONTACT Ali Mehdizadeh <email xlink:href="mailto:alimeh111@gmail.com">alimeh111@gmail.com</email><institution>Department and Faculty of Medical Sciences, Shahid Beheshti University of
Medical Sciences</institution>, <city>Tehran</city><postal-code>19839-63113</postal-code>, <country>Iran</country>; </corresp><corresp id="AN0002">Mohammad Asadi <email xlink:href="mailto:drsinaasadi@gmail.com">drsinaasadi@gmail.com</email><institution>Department and Faculty of Medical Sciences, Shahid Beheshti University of
Medical Sciences</institution>, <addr-line>7th Floor, Bldg No.2 SBUMS, Arabi Ave,
Daneshjoo Blvd</addr-line>, <city>Tehran</city>, <postal-code>19839-63113</postal-code>,
<state>Velenjak</state>, <country>Iran</country></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>20</day><month>9</month><year>2020</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2020</year></pub-date><volume>42</volume><issue>1</issue><fpage seq="128">969</fpage><lpage>977</lpage><permissions><copyright-statement>&#x000a9; 2020 The Author(s). Published by Informa UK Limited, trading as
Taylor &#x00026; Francis Group.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted
use, distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="IRNF_42_1818580.pdf"/><abstract><title>Abstract</title><sec><title>Aim</title><p> The aim of this study was to evaluate the effects of curcumin in an experimental model
of busulfan-induced renal toxicity with emphasis on importance of histological
alterations.</p></sec><sec><title>Methods</title><p> In this study, we utilized 32 adult male Wistar rats (250&#x02009;&#x000b1;&#x02009;10&#x02009;g). All the animals
were divided into four experimental groups randomly: (I) Control; (II) Busulfan
(40&#x02009;mg/kg); (III) Olive oil; and (IV) Curcumin (80&#x02009;mg/kg/day). Finally, the rats were
euthanized and kidney tissues were taken for histopathology experiments, serum BUN, and
creatinine level, reactive oxygen species (ROS) production and glutathione disulfide
(GSH) activity.</p></sec><sec><title>Results</title><p> Our result showed that the reduction in body weight and kidney weight in busulfan
groups in comparison with the control and curcumin groups. The result in this study also
showed that the reduction in BUN, creatinine, and ROS production in curcumin groups in
comparison with the busulfan group together with an increasing of GSH activity compared
to busulfan induced rats.</p></sec><sec><title>Conclusion</title><p> Our results of this study indicated that that the reduction in body weight, kidney
weight, total volume of kidney, total length of nephron tubules, and numerical density
of glomeruli and nephron tubules in busulfan groups in comparison with the control and
curcumin groups However, curcumin can be an alternative choice for therapeutically and
research purposes in the disturbing kidney after treatment with busulfan.</p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>Busulfan</kwd><kwd>curcumin</kwd><kwd>male rats</kwd><kwd>renal toxicity</kwd></kwd-group><counts><fig-count count="6"/><table-count count="0"/><page-count count="9"/><word-count count="4501"/></counts></article-meta></front><body><sec sec-type="intro" id="S0001" disp-level="1"><title>Introduction</title><p>Busulfan is a chemotherapy drug and it is a cell cycle nonspecific alkylating
antineoplastic agent, which is a chemical designation is 1,4-butanediol dimethanesulfonate
and it is in the class of alkyl sulfonates [<xref rid="CIT0001" ref-type="bibr">1</xref>].
The chemical structure of busulfan contains two easily displaced methane sulfonate groups on
opposite ends of a butane chain. Hydrolysis of these groups produces highly reactive,
positively charged carbonium ions that alkylate and damage DNA molecules. The busulfan
reacts with guanine molecules and cysteine molecules on histone proteins through a
nucleophilic substitution reaction, forming DNA intrastrand or interstrand cross-links
[<xref rid="CIT0002" ref-type="bibr">2</xref>]. Busulfan by alkylating activity can
produce alterations of cell replication, gene transcription, and DNA damage repair [<xref rid="CIT0001" ref-type="bibr">1</xref>].</p><p>The impact of chemotherapy on improving and prolonging the life of patients with kinds of
cancers is undeniable, but it often involves severe side effects including cognitive
problems, early menopause, heart diseases, bone and joint disorders, secondary cancers,
disrupt the blood&#x02013;testis barrier, and renal diseases [<xref rid="CIT0003" ref-type="bibr">3&#x02013;5</xref>].</p><p>Nephrotoxicity caused by chemotherapeutic agents makes a significant complication limiting
the efficacy of the treatment [<xref rid="CIT0006" ref-type="bibr">6</xref>]. A variety of
disorders associated with renal function can results from some chemotherapeutic agents such
as busulfan, including inflamed kidney tissue, papillary necrosis, urothelial alterations,
hemorrhagic cystitis, acute tubular necrosis, and also infarction [<xref rid="CIT0006" ref-type="bibr">6</xref>,<xref rid="CIT0007" ref-type="bibr">7</xref>]. The clinical
observations indicated that cancer patients treated with busulfan/Cyclophosphamide (Bu/Cy)
can potentially suffer from ovarian failure, infertility, and renal dysfunction. It means
that the use of Bu/Cy compound affects the ovarian function and also it has been made clear
that Bu/Cy combination has side effects on the several organs such as spleen, lungs, and
kidneys. Although, it does not seem to have much impacts on the heart, liver, stomach, and
pancreas [<xref rid="CIT0008" ref-type="bibr">8</xref>,<xref rid="CIT0009" ref-type="bibr">9</xref>]. In previous studies, histological assessments of animal model of ovarian
failure induced by Bu/Cy demonstrated impairments in ovarian tissue. A sharp edema in the
cortical and medullary layers of kidneys, shrinkage of the glomeruli, and persistent edema
in the tubular structures were also reported. Due to increasing use and on the other hand,
the side effects of chemotherapeutic drugs, somewhat safer natural products provide an
appropriate and rich origin for exploring adjuvant factors that hinder and decrease the side
effects of chemotherapy. In this regard, curcumin can be suggested [<xref rid="CIT0010" ref-type="bibr">10</xref>,<xref rid="CIT0011" ref-type="bibr">11</xref>]. Curcumin is a
functional polyphenolic compound from the plant Curcuma longa which has the usage as a
natural remedy for a long time in various Asian regions owing to its curative effects on
disorders such as diabetes, liver and kidney diseases, rheumatoid diseases, infectious
diseases, and cancer [<xref rid="CIT0012" ref-type="bibr">12&#x02013;14</xref>].
Several studies have shown that curcumin has potent anti-oxidative, anti-microbial,
anti-inflammatory, and anticancer operations. Furthermore, current studies have shown that
curcumin is capable to hinder carcinogenesis in sensitive cells after chemotherapy and
protects normal cells from the damages caused by chemotherapy [<xref rid="CIT0012" ref-type="bibr">12</xref>,<xref rid="CIT0013" ref-type="bibr">13</xref>]. According to
antioxidative and anti-inflammatory properties of curcumin, a protective effect against
kidney damages and renal toxicity following chemotherapeutic drugs administration has been
reported [<xref rid="CIT0015" ref-type="bibr">15</xref>,<xref rid="CIT0016" ref-type="bibr">16</xref>]. Furthermore, it has been revealed that curcumin is able to show protecting
effects against ischemic renal impairment by upregulation of antioxidant gene expression,
mainly Mn-superoxide dismutase, the antioxidant enzyme in the mitochondrial matrix [<xref rid="CIT0015" ref-type="bibr">15</xref>,<xref rid="CIT0016" ref-type="bibr">16</xref>].
For the reason that many people are suffering worldwide from side effects of chemotherapy
drugs, the aim of this study was to estimate the effects of curcumin in an experimental
model of busulfan-induced renal toxicity with emphasis on importance of histological
alterations.</p></sec><sec sec-type="methods" id="S0002" disp-level="1"><title>Methods and materials</title><sec id="S0002-S2001" disp-level="2"><title>Animal models</title><p>In this study, 32 adult male Wistar rats (250&#x02009;&#x000b1;&#x02009;10&#x02009;g) were collected from the laboratory
animal center of Pasture Institute and were approved by the the Medical Ethics Committee
at Shahid Beheshti University of Medical Sciences, Tehran, Iran (IR.SBMU.MSP.REC
1399.027). The rats were divided into four experimental groups: Group I (Control group):
The animals of this group were intact. Group II (Busulfan group): The animals of this
group were received a three-dose of busulfan (40&#x02009;mg/kg) in 0&#x02009;day, 7&#x02009;days and 21&#x02009;days
intraperitoneally (IP). Group III (Olive oil): The rats of this group were received a
three dose of busulfan 40&#x02009;mg/kg IP&#x02009;+&#x02009;daily receiving olive oil by gastric gavage for
30&#x02009;days after the last injection of busulfan. Group IV (Curcumin): The animals of this
group were received a three dose of busulfan 40&#x02009;mg/kg IP) + curcumin 80&#x02009;mg/kg/day, which
was dissolved in olive oil by gastric gavage for 30&#x02009;days after the last injection of
busulfan. Each group comprised eight rats that were kept in under standard situation, at
room temperature (22&#x02013;24&#x02009;&#x000b0;C), and with a 12:12-h light-dark schedule; the animals also had
optional availability to water and food. The rats&#x02019; body weights were monitored at first of
study and the end of study. The kidney weights were also measured at the end of study.</p></sec><sec id="S0002-S2002" disp-level="2"><title>Blood collection</title><p>At the end of the experiment, rats were anesthetized by ketamine (100&#x02009;mg/kg) and xylazine
(5&#x02009;mg/kg) and then blood samples were obtained from the left ventricle of heart. The blood
samples were allowed to coagulate and then centrifuged at 3000&#x02009;rpm for 10&#x02009;min. The Serum
were separated for measurement of blood urea nitrogen (BUN) and serum creatinine.</p></sec><sec id="S0002-S2003" disp-level="2"><title>Reactive oxygen species in testicular tissue</title><p>After isolation testis cells with trypsin EDTA samples with PBS for 5&#x02009;min at 4&#x02009;&#x000b0;C was
centrifuged at 1200rpm. Then the DCFDA was added to the sample at a concentration of 20&#x02009;&#x000b5;M
in a 100&#x02009;&#x000b5;l aliquot and stored in a 37&#x02009;&#x000b0;C incubator for 45&#x02009;min in the dark. Finally, the
sample was examined by a flow cytometer with a wavelength of 495&#x02009;nm.</p></sec><sec id="S0002-S2004" disp-level="2"><title>Glutathione disulfide content assessments</title><p>GPX assay kit (Zelbio GmbH) was used to determine GPX in testis tissue samples with
5&#x02009;U/ml sensitivity (5KU/L). In this essay, GPX activity unit was considered as the amount
of the sample that will catalyze decomposition of 1&#x000b5;mole of GSH to GSSG in one minute.
Aliquots of the testicular cells suspension (0.5&#x02009;mL) that were previously stained with OPA
and NEM probe (5&#x02009;&#x003bc;M) were separated from the incubation medium by 1&#x02009;min centrifugation at
1000&#x02009;rpm. The cell pellet was then suspended in 2&#x02009;mL of fresh incubation medium. This
washing process was carried out twice to remove the fluorescent dye from the media. Each
sample was measured in quarts cuvettes using a Shimadzu RF5000U fluorescence
spectrophotometer set for at 495&#x02009;nm excitation and 530&#x02009;nm emission wavelengths.</p></sec><sec id="S0002-S2005" disp-level="2"><title>Tissue preparation</title><p>At the end of the experiment, the animals were euthanized and their kidneys were
collected and fixed in paraformaldehyde 4%. Then the kidneys were fixed in paraffin blocks
and cut into 5 and 25&#x02009;&#x003bc;m thick segments with a usage of microtome. For the microscopic
definitive analysis of each group, slides were stained with hematoxylin and eosin
(H&#x00026;E).</p></sec><sec id="S0002-S2006" disp-level="2"><title>Estimating the volume of kidney and interstitial tissue</title><p>By using a microscope connected to a camera, the live image of each kidney section was
evaluated. By systematic uniform random sampling (SURS), 8&#x02013;10 sections were obtained and
analyzed for each kidney. Using the stereological software designed at Stereology center
(Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti
University of Medical Sciences, Tehran, Iran). Total volumes of the kidney and
interstitial tissue were assessed using the Cavalieri method. The volume of the kidney and
interstitial tissue was estimated using the following formula [<xref rid="CIT0017" ref-type="bibr">17</xref>,<xref rid="CIT0018" ref-type="bibr">18</xref>]: <disp-formula id="M0001"><alternatives><graphic xlink:href="IRNF_A_1818580_M0001.jpg" position="float" orientation="portrait"/><mml:math id="d1e313"><mml:msub><mml:mrow><mml:mi mathvariant="normal">V</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">total</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="false">&#x02211;</mml:mo><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mo>&#x000d7;</mml:mo><mml:mi mathvariant="normal">t</mml:mi><mml:mo>&#x000d7;</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mrow><mml:mo>,</mml:mo></mml:math></alternatives></disp-formula> where &#x003a3;P is the total points hitting the kidney sections,
a/p is the area correlated with each point, and t is the distance between the sampled
sections.</p></sec><sec id="S0002-S2007" disp-level="2"><title>Estimating the length of nephron tubules</title><p>The length density of the nephron tubules was estimated by superimposed an unbiased
counting frame randomly on the live image of each kidney section. The length density of
tubules using the formula [<xref rid="CIT0017" ref-type="bibr">17</xref>,<xref rid="CIT0019" ref-type="bibr">19</xref>]: <disp-formula id="M0002"><alternatives><graphic xlink:href="IRNF_A_1818580_M0002.jpg" position="float" orientation="portrait"/><mml:math id="d1e354"><mml:msub><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">v</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:mo>&#x000d7;</mml:mo><mml:mrow><mml:mo stretchy="false">&#x02211;</mml:mo><mml:mrow><mml:mi mathvariant="normal">Q</mml:mi></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mo stretchy="false">&#x02211;</mml:mo><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mo>&#x000d7;</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">f</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:math></alternatives></disp-formula> where &#x003a3;Q is the total number of the nephron tubules, a/f
is the area per frame, and &#x003a3;P is the total points superimposed on the kidney tissue. We
estimated the total length of the tubules by multiplying the length density (Lv) by the
total volume of the kidney. The total length of the tubule &#x02018;L&#x02019; was calculated by
multiplying the length density (LV) by the total volume of the tubules. <disp-formula id="M0003"><alternatives><graphic xlink:href="IRNF_A_1818580_M0003.jpg" position="float" orientation="portrait"/><mml:math id="d1e393"><mml:mi>L</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi></mml:mrow></mml:msub><mml:mo>&#x000d7;</mml:mo><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="italic">total</mml:mi></mml:mrow></mml:msub><mml:mo>.</mml:mo></mml:math></alternatives></disp-formula>
</p></sec><sec id="S0002-S2008" disp-level="2"><title>Estimating the number of glomeruli and nephron tubules</title><p>The total number of glomeruli and nephron tubules was determined using the optical
disector method. An unbiased counting frame was superimposed on the live image of each
kidney section. To measure the z-axis traveling, we used a microcator was attached to the
stage of the microscope. The height of the disector was defined as the section thickness
excluding the upper and lower 20% was considered as the guard zone. Using the following
equation, the number density (Nv) of different cell types was estimated [<xref rid="CIT0017" ref-type="bibr">17</xref>,<xref rid="CIT0020" ref-type="bibr">20</xref>]:
<disp-formula id="M0004"><alternatives><graphic xlink:href="IRNF_A_1818580_M0004.jpg" position="float" orientation="portrait"/><mml:math id="d1e423"><mml:mrow><mml:mi>N</mml:mi><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mstyle displaystyle="true"><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mo>&#x02212;</mml:mo></mml:msup></mml:mrow></mml:mstyle></mml:mrow><mml:mrow><mml:mstyle displaystyle="true"><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x000d7;</mml:mo><mml:mfrac><mml:mi>a</mml:mi><mml:mi>f</mml:mi></mml:mfrac><mml:mo>&#x000d7;</mml:mo><mml:mi>h</mml:mi></mml:mrow></mml:mstyle></mml:mrow></mml:mfrac><mml:mo>&#x000d7;</mml:mo><mml:mfrac><mml:mi>t</mml:mi><mml:mrow><mml:mi>B</mml:mi><mml:mi>A</mml:mi></mml:mrow></mml:mfrac></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula> where &#x003a3;Q is the total number of the counted glomeruli and
tubules, h is the tissue thickness considered for counting, a/f is the area per frame, and
&#x003a3;P is the total number of the counting frames in all fields. Also, h is the height of the
dissector, t is the real section thickness measured using the microcator when the Q&#x02009;&#x02212;&#x02009;is
counted, and BA is the tissue section thickness. The result of the equation was then
multiplied by the total volume of the kidney to acquire the total number of glomeruli and
nephron tubules. <disp-formula id="M0005"><alternatives><graphic xlink:href="IRNF_A_1818580_M0005.jpg" position="float" orientation="portrait"/><mml:math id="d1e463"><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="italic">total</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi></mml:mrow></mml:msub><mml:mo>&#x000d7;</mml:mo><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="italic">total</mml:mi></mml:mrow></mml:msub><mml:mo>.</mml:mo></mml:math></alternatives></disp-formula>
</p></sec><sec id="S0002-S2009" disp-level="2"><title>Statistical analysis</title><p>Data were analyzed using One-Way ANOVA and the Kruskall&#x02013;Wallis test. Results were
rendered as average&#x02009;&#x000b1;&#x02009;SD. The significance of comparisons was denoted by <italic>p</italic>&#x02009;&#x02264;&#x02009;.05.</p></sec></sec><sec sec-type="results" id="S0003" disp-level="1"><title>Results</title><sec id="S0003-S2001" disp-level="2"><title>Body weight and kidney weight</title><p>Busulfan treated rats from groups 2, 3, and 4 had significantly decreased body weight and
kidney weight at the conclusion of the study (<italic>p</italic>&#x02009;&#x0003c;&#x02009;.05;
<xref ref-type="fig" rid="F0001">Figure 1</xref>). Our results of this study indicated
that the decrease in body weight and kidney weight in busulan groups compared to the
control and curcumin groups (<xref ref-type="fig" rid="F0001">Figure 1</xref>).</p><fig id="F0001" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>The effects of curcumin on the busulfan-induced impairment in body weight and kidney
weight. Mean&#x02009;&#x000b1;&#x02009;SD of the body weight of rats and the weight of kidney in study groups
(*<italic>p</italic>&#x02009;&#x0003c;&#x02009;.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;.01, and ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;.001). In the study
groups (six animals per group) as compared by the ANOVA and LSD. ANOVA: analysis of
variance; CM: conditioned medium; LSD: least significant difference.</p></caption><graphic content-type="black-white" xlink:href="IRNF_A_1818580_F0001_B"/></fig></sec><sec id="S0003-S2002" disp-level="2"><title>Assessment of biochemical parameters</title><p>The data represented in <xref ref-type="fig" rid="F0002">Figure 2</xref>, revealed that
administration of busulfan at a dose of 40&#x02009;mg/Kg significantly increase BUN and creatinine
when compared to control and curcumin groups (<italic>p</italic>&#x02009;&#x0003c;&#x02009;.05).
Whereas, curcumin was none notably increased BUN and creatinine in comparison with the
control groups (<italic>p</italic>&#x02009;&#x0003c;&#x02009;.05). Interestingly, treatment of
rats with curcumin significantly decreased BUN and creatinine (<xref ref-type="fig" rid="F0002">Figure 2</xref>).</p><fig id="F0002" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>The effects of curcumin on the busulfan-induced impairment in BUN and serum
creatinine. Mean&#x02009;&#x000b1;&#x02009;SD of the BUN and serum creatinine in study groups (*<italic>p</italic>&#x02009;&#x0003c;&#x02009;.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;.01, and
***<italic>p</italic>&#x02009;&#x0003c;&#x02009;.001). In the study groups (six animals per
group) as compared by the ANOVA and LSD. ANOVA: analysis of variance; CM: conditioned
medium; LSD: least significant difference.</p></caption><graphic content-type="black-white" xlink:href="IRNF_A_1818580_F0002_B"/></fig></sec><sec id="S0003-S2003" disp-level="2"><title>Effect of scrotal hyperthermia on reactive oxygen species (ROS) production</title><p>The effect of busulfan on the formation of ROS was assayed, using flow cytometry. The
significant peak shifting shows that, ROS production in the kidney tissue exposed to
busulfan compared to control and curcumin groups significantly increased (<italic>p</italic>&#x02009;&#x0003c;&#x02009;.001, <italic>p</italic>&#x02009;&#x0003c;&#x02009;.001),
respectively (<xref ref-type="fig" rid="F0003">Figure 3(A)</xref>). The results also
revealed that the reduction in the ROS production in curcumin groups in comparison to the
busulfan and olive oil (<italic>p</italic>&#x02009;&#x0003c;&#x02009;.001, <italic>p</italic>&#x02009;&#x0003c;&#x02009;.001), respectively (<xref ref-type="fig" rid="F0003">Figure
3(A)</xref>). Also, there was significant different between Control group with curcumin
group (<italic>p</italic>&#x02009;&#x0003c;&#x02009;.05; <xref ref-type="fig" rid="F0003">Figure
3(A)</xref>). Our results of ROS assay showed remarkable improve rate following curcumin
treatment.</p><fig id="F0003" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>The effect of curcumin on ROS production and level of GSH in study groups. (A and B)
Mean&#x02009;&#x000b1;&#x02009;SD of the ROS production and GPX activity of kidney in the study groups
(*<italic>p</italic>&#x02009;&#x0003c;&#x02009;.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;.01, and ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;.001).</p></caption><graphic content-type="black-white" xlink:href="IRNF_A_1818580_F0003_B"/></fig></sec><sec id="S0003-S2004" disp-level="2"><title>Thiols metabolism</title><p>We assessed concentration of glutathione (GSH) in different groups. As <xref ref-type="fig" rid="F0003">Figure 3(B)</xref> shows, concentration of GSH in busulfan
group significantly reduced in comparison to control and curcumin groups (<italic>p</italic>&#x02009;&#x0003c;&#x02009;.001, <italic>p</italic>&#x02009;&#x0003c;&#x02009;.01; <xref ref-type="fig" rid="F0003">Figure 3(B)</xref>). The results of this study also showed
that the GSH significantly decreased in olive oil group in comparison with control and
curcumin groups (<italic>p</italic>&#x02009;&#x0003c;&#x02009;.001, <italic>p</italic>&#x02009;&#x0003c;&#x02009;.01; <xref ref-type="fig" rid="F0003">Figure 3(B)</xref>). Nonetheless,
there is a significant difference between control group comparison to the curcumin groups
(<italic>p</italic>&#x02009;&#x0003c;&#x02009;.01; <xref ref-type="fig" rid="F0003">Figure
3(B)</xref>). Antioxidant assay of this study showed remarkable improvement rate
following curcumin therapy.</p></sec><sec id="S0003-S2005" disp-level="2"><title>Total volume of kidney and interstitial tissue</title><p>The total volume of kidney was remarkably reduced in the busulfan groups in comparison
with the control and curcumin groups (<italic>p</italic>&#x02009;&#x0003c;&#x02009;.05).
Administration of curcumin in the busulfan&#x02009;+&#x02009;curcumin groups ameliorate the reduction of
kidney volume in comparison with the busulfan group, but the volume of interstitial tissue
increased after the busulfan injection in comparison with the control and curcumin groups
(<italic>p</italic>&#x02009;&#x0003c;&#x02009;.05; <xref ref-type="fig" rid="F0004">Figure
4</xref>).</p><fig id="F0004" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>(A and B) The effects of curcumin on the busulfan-induced impairment in total volume
of kidney and interstitial tissue. Mean&#x02009;&#x000b1;&#x02009;SD of the total volume of kidney and
interstitial tissue in study groups. (*<italic>p</italic>&#x02009;&#x0003c;&#x02009;.05,
**<italic>p</italic>&#x02009;&#x0003c;&#x02009;.01, and ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;.001). In the study groups (six animals per group) as compared by the
ANOVA and LSD. (C) A schematic figure showing the protocol of study for Cavalieri
method. ANOVA, analysis of variance; CM, conditioned medium; LSD, least significant
difference.</p></caption><graphic content-type="color" xlink:href="IRNF_A_1818580_F0004_C"/></fig></sec><sec id="S0003-S2006" disp-level="2"><title>Total length of nephron tubules</title><p>The total length of nephron tubules was notably reduced in the rats treated with busulfan
in comparison with the control and curcumin groups (<italic>p</italic>&#x02009;&#x0003c;&#x02009;.05). The total length of nephron tubules increased after the
administration of curcumin in comparison with the busulfan group (<italic>p</italic>&#x02009;&#x0003c;&#x02009;.05; <xref ref-type="fig" rid="F0005">Figures 5</xref> and <xref ref-type="fig" rid="F0006">6</xref>).</p><fig id="F0005" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>(A&#x02013;C) The effects of curcumin on the busulfan-induced impairment in the number of
glomeruli, nephron tubules, and tubule length. Mean&#x02009;&#x000b1;&#x02009;SD of the number of glomeruli,
nephron tubules, and tubule length in study groups (*<italic>p</italic>&#x02009;&#x0003c;&#x02009;.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;.01, and ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;.001). In the study groups (six animals per group) as
compared by the ANOVA and LSD. (D) A schematic figure showing the protocol of study
for optical disector method. ANOVA: analysis of variance; CM: conditioned medium; LSD:
least significant difference.</p></caption><graphic content-type="color" xlink:href="IRNF_A_1818580_F0005_C"/></fig><fig id="F0006" orientation="portrait" position="float"><label>Figure 6.</label><caption><p>Photomicrograph of the testis stained with H&#x00026;E (40&#x000d7;). (A&#x02013;D) Control group, (D&#x02013;F)
Glomeruli (G), proximal convoluted tubule (P), distal convoluted tubule, collecting
tubule (CT).</p></caption><graphic content-type="color" xlink:href="IRNF_A_1818580_F0006_C"/></fig></sec><sec id="S0003-S2007" disp-level="2"><title>Number of glomeruli and tubules</title><p>The numerical density of glomeruli and nephron tubules in animals with busulfan treated
decreased in comparison with the control and curcumin groups (<italic>p</italic>&#x02009;&#x0003c;&#x02009;.05). Likewise, the reduction of numerical density of glomeruli and
nephron tubules averted after the administration of curcumin in comparison with the
busulfan group (<xref ref-type="fig" rid="F0005">Figures 5</xref> and <xref ref-type="fig" rid="F0006">6</xref>).</p></sec></sec><sec sec-type="discussion" id="S0004" disp-level="1"><title>Discussion</title><p>Acute and chronic renal failure are commonly challenged during chemotherapy. Hence, an
essential consideration in limiting the use of such drugs. While some approaches exist to
prevent nephrotoxicity, no suggested definite treatment is currently presented [<xref rid="CIT0015" ref-type="bibr">15</xref>]. Curcumin, an attractive natural herbal
component, is recognized to have anti-inflammatory, anti-apoptotic, and antioxidant
possessions in different pathologies [<xref rid="CIT0020" ref-type="bibr">20</xref>]. In the
present study, we explore the effectiveness of curcumin therapy for the potential treatment
for tissue damages associated with chemotherapy, particularly nephrotoxicity.</p><p>In several researches, it has been stated that curcumin averts and ameliorates the severity
of cisplatin-induced nephrotoxicity, through preventing cytokines and chemokines such as
TNF-&#x003b1; and IL-1&#x003b2; and also scavenging free radicals [<xref rid="CIT0020" ref-type="bibr">20</xref>,<xref rid="CIT0021" ref-type="bibr">21</xref>]. Although the major mechanisms
of chemotherapeutic agents-induced nephrotoxicity are complex, previous studies have
demonstrated the role of several interconnected aspects involved in chemotherapeutic
drugs-induced renal damages [<xref rid="CIT0022" ref-type="bibr">22</xref>]. These
prominence causes include toxic effects on renal cells, DNA and mitochondrial damages,
inflammation, oxidative stress, apoptosis, and related pathways [<xref rid="CIT0023" ref-type="bibr">23&#x02013;25</xref>]. In this study, the most important findings
are that curcumin treatment ameliorates the following conditions related with
busulfan-associated renal toxicity: The first, histological and structural improvement of
acute renal damages and the next one, renal dysfunction (kidney weight and biochemical
parameters like blood urea nitrogen (BUN) along with serum creatinine).</p><p>According to our studies, this seems to be the first report based on stereological
evaluations regarding the effects of curcumin on renal cellular structure in
busulfan-induced nephrotoxicity. For this purpose, estimating the volume of kidney and its
interstitial tissue, estimating the length of nephron tubules, and estimating the number of
glomeruli and nephron tubules were done by means of specific stereological techniques.
According to our data, it was obtained that the total volume of kidney, the total length of
nephron tubules, and the numerical density of glomeruli and nephron tubules were
significantly reduced following injection of busulfan in rats. On the other hand,
administration of curcumin was capable to preclude these morphological atrophy of kidney in
comparison with the busulfan group, but the volume of interstitial tissue increased after
the busulfan injection in comparison with the control and curcumin-treated rats. Also in
this study we perceived an increase in GSH following the treatment of the mice with curcumin
and likewise in this study we observed the reduction in ROS production, in curcumin-treated
rats.</p><p>Based on a previous probe, it has been demonstrated that following simulation of a mouse
model of ovarian failure induced by mixture of Bu/Cy administration as a chemotherapeutic
combination, after 4&#x02009;weeks of treatment, a sharp edema of the cortical and medullar layers
was observable in the kidneys, and after 12 weeks&#x02019; histological examinations of kidneys
confirmed the shrinkage of the glomeruli and persistent edema in tubules. In Yan Jiang
<italic>et&#x000a0;al.</italic> study less effect of Bu/Cy treatment on kidneys and
also edema in the renal tubules after 30&#x02009;days of treatment was noticeable [<xref rid="CIT0008" ref-type="bibr">8</xref>]. Reviewing the works about properties and effects
of curcumin on urinary system disclosed the role of curcumin in prevention of renal fibrosis
through deactivation of TGF-b1-induced epithelial mesenchymal transition process in tubular
cells by affecting the snail-1, different interleukins (ILs), and matrix metalloproteinases
(MMPs) [<xref rid="CIT0020" ref-type="bibr">20</xref>,<xref rid="CIT0026" ref-type="bibr">26</xref>]. According to the previous studies, epithelial mesenchymal transition not only
is an essential developmental phase of kidney, but also has a significant role in several
adult pathologies, mainly renal cancer and fibrosis [<xref rid="CIT0026" ref-type="bibr">26</xref>].</p><p>Histopathological findings and evaluating renal function parameters in Yeter et&#x000a0;al. study
revealed that following exposure to a single dose of cisplatin, a chemotherapeutic drug,
tubular necrosis, luminal dilatation, and inflammatory cell infiltration in the rat kidneys
were detected, particularly in the corticomedullary area [<xref rid="CIT0022" ref-type="bibr">22</xref>]. Subsequently, the curcumin treatment significantly decreased the
harshness of damages. Furthermore, serum urea and creatinine values of the cisplatin-induced
group were significantly increased [<xref rid="CIT0020" ref-type="bibr">20</xref>]. And this
increase was significantly reduced after curcumin administration. It has been made clear
that one of the potential mechanisms associated with chemotherapeutic drugs such as
cisplatin and busulfan nephrotoxicity, is the creation of reactive oxygen species (ROS),
also diminution of function of the antioxidant system, and finally, accumulation of lipid
peroxidation in the kidneys [<xref rid="CIT0027" ref-type="bibr">27&#x02013;29</xref>].</p><p>Further experimental outcomes from Zhou <italic>et&#x000a0;al.</italic> exhibited that
dose-dependently treatment with chemotherapeutic agent mitomycin (MMC) amplified the levels
of creatinine (Cr) and blood urea nitrogen (BUN) in mice, signifying that MMC provoked
complicated injuries to the kidneys. After administration of curcumin, the levels of Cr and
BUN were notably declined and became like the healthy samples. On the other hand, the
impairments were less apparent in the experimental group of combination of curcumin and
cisplatin treatment, obviously demonstrating a prospective activity of curcumin in
preventing and even cure of renal injuries [<xref rid="CIT0030" ref-type="bibr">30</xref>].
Their results more confirm that curcumin can be considered as a potential natural drug and
ameliorates chemotherapy-associated nephrotoxicity.</p></sec><sec sec-type="conclusions" id="S0005" disp-level="1"><title>Conclusions</title><p>Therefore, it can be concluded that the curcumin showed protective effect on
histopathologic changes and BUN and creatinine levels and also ROS production and GSH
activity of rat kidney exposed to busulfan. However, curcumin can be an alternative choice
for therapeutically and research purposes in the disturbing kidney after treatment with
busulfan.</p></sec></body><back><ack><title>Acknowledgements</title><p>This study is related to the project from Student Research Committee, Shahid Beheshti
University of Medical Sciences, Tehran, Iran. We also appreciate the &#x02018;Student Research
Committee&#x02019; and &#x02018;Research &#x00026; Technology Chancellor&#x02019; in Shahid Beheshti University of
Medical Sciences.</p></ack><sec id="S0006" disp-level="1" sec-type="COI-statement"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the author(s).</p></sec><sec id="S0007" disp-level="1"><title>Ethical approval</title><p>The authors declare that all experiments protocols were approved by the Ethics Committee,
deputy of research, Shahid Beheshti University of Medical Sciences, Tehran, Iran (IR. SBMU.
SM. REC. 1399.027). All methods were carried out in accordance with relevant guidelines and
regulations.</p></sec><ref-list><title>References</title><ref id="CIT0001"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galaup</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Paci</surname><given-names>A.</given-names></name></person-group>
<article-title>Pharmacology of dimethanesulfonate alkylating agents: busulfan and
treosulfan</article-title>. <source>Expert Opin Drug Metab Toxicol</source>.
<year>2013</year>;<volume>9</volume>(<issue>3</issue>):<fpage>333</fpage>&#x02013;<lpage>347</lpage>.<pub-id pub-id-type="pmid">23157726</pub-id></mixed-citation></ref><ref id="CIT0002"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hartley</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Fox</surname><given-names>BW.</given-names></name></person-group>
<article-title>Cross-linking between histones and DNA following treatment with a series of
dimethane sulphonate esters</article-title>. <source>Cancer Chemother
Pharmacol</source>.
<year>1986</year>;<volume>17</volume>(<issue>1</issue>):<fpage>56</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">3009042</pub-id></mixed-citation></ref><ref id="CIT0003"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kasi</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Tamilselvam</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Skalicka-Wo&#x0017a;niak</surname><given-names>K</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Molecular targets of curcumin for cancer therapy: an updated
review</article-title>. <source>Tumour Biol</source>.
<year>2016</year>;<volume>37</volume>(<issue>10</issue>):<fpage>13017</fpage>&#x02013;<lpage>13028</lpage>.<pub-id pub-id-type="pmid">27468716</pub-id></mixed-citation></ref><ref id="CIT0004"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oun</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Moussa</surname><given-names>YE</given-names></name>, <name name-style="western"><surname>Wheate</surname><given-names>NJ.</given-names></name></person-group>
<article-title>The side effects of platinum-based chemotherapy drugs: a review for
chemists</article-title>. <source>Dalton Trans</source>.
<year>2018</year>;<volume>47</volume>(<issue>19</issue>):<fpage>6645</fpage>&#x02013;<lpage>6653</lpage>.<pub-id pub-id-type="pmid">29632935</pub-id></mixed-citation></ref><ref id="CIT0005"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brinster</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Zimmermann</surname><given-names>JW.</given-names></name></person-group>
<article-title>Spermatogenesis following male germ-cell transplantation</article-title>.
<source>Proc Natl Acad Sci USA</source>.
<year>1994</year>;<volume>91</volume>(<issue>24</issue>):<fpage>11298</fpage>&#x02013;<lpage>11302</lpage>.<pub-id pub-id-type="pmid">7972053</pub-id></mixed-citation></ref><ref id="CIT0006"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Assayag</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rouvier</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gauthier</surname><given-names>M</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Renal failure during chemotherapy: renal biopsy for assessing subacute
nephrotoxicity of pemetrexed</article-title>. <source>BMC Cancer</source>.
<year>2017</year>;<volume>17</volume>(<issue>1</issue>):<fpage>770</fpage>.<pub-id pub-id-type="pmid">29145816</pub-id></mixed-citation></ref><ref id="CIT0007"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arany</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Safirstein</surname><given-names>RL.</given-names></name></person-group>
<article-title>Cisplatin nephrotoxicity</article-title>. <source>Semin Nephrol</source>.
<year>2003</year>;<volume>23</volume>(<issue>5</issue>):<fpage>460</fpage>&#x02013;<lpage>464</lpage>.<pub-id pub-id-type="pmid">13680535</pub-id></mixed-citation></ref><ref id="CIT0008"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Qi</surname><given-names>H-j</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Accelerated ovarian aging in mice by treatment of busulfan and
cyclophosphamide</article-title>. <source>J Zhejiang Univ Sci B</source>.
<year>2013</year>;<volume>14</volume>(<issue>4</issue>):<fpage>318</fpage>&#x02013;<lpage>324</lpage>.<pub-id pub-id-type="pmid">23549849</pub-id></mixed-citation></ref><ref id="CIT0009"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maltaris</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Seufert</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Fischl</surname><given-names>F</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>The effect of cancer treatment on female fertility and strategies for
preserving fertility</article-title>. <source>Eur J Obstet Gynecol Reprod Biol</source>.
<year>2007</year>;<volume>130</volume>(<issue>2</issue>):<fpage>148</fpage>&#x02013;<lpage>155</lpage>.<pub-id pub-id-type="pmid">16979280</pub-id></mixed-citation></ref><ref id="CIT0010"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sahebkar</surname><given-names>A.</given-names></name></person-group>
<article-title>Molecular mechanisms for curcumin benefits against ischemic
injury</article-title>. <source>Fertil Steril</source>.
<year>2010</year>;<volume>94</volume>(<issue>5</issue>):<fpage>e75</fpage>&#x02013;<lpage>e6</lpage>.<pub-id pub-id-type="pmid">20797714</pub-id></mixed-citation></ref><ref id="CIT0011"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hewlings</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Kalman</surname><given-names>DS.</given-names></name></person-group>
<article-title>Curcumin: a review of its&#x02019; effects on human health</article-title>.
<source>Foods</source>.
<year>2017</year>;<volume>6</volume>(<issue>10</issue>):<fpage>92</fpage>.</mixed-citation></ref><ref id="CIT0012"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Barua</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Sulakhiya</surname><given-names>K</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Curcumin ameliorates cisplatin-induced nephrotoxicity and potentiates its
anticancer activity in SD rats: potential role of curcumin in breast cancer
chemotherapy</article-title>. <source>Front Pharmacol</source>.
<year>2017</year>;<volume>8</volume>:<fpage>132</fpage>.<pub-id pub-id-type="pmid">28420987</pub-id></mixed-citation></ref><ref id="CIT0013"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Si</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Bao</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>L</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Dexmedetomidine protects against renal ischemia and reperfusion injury by
inhibiting the JAK/STAT signaling activation</article-title>. <source>J Transl
Med</source>.
<year>2013</year>;<volume>11</volume>(<issue>1</issue>):<fpage>141</fpage>.<pub-id pub-id-type="pmid">23759023</pub-id></mixed-citation></ref><ref id="CIT0014"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pulido-Moran</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Moreno-Fernandez</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ramirez-Tortosa</surname><given-names>C</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Curcumin and health</article-title>. <source>Molecules</source>.
<year>2016</year>;<volume>21</volume>(<issue>3</issue>):<fpage>264</fpage>.<pub-id pub-id-type="pmid">26927041</pub-id></mixed-citation></ref><ref id="CIT0015"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Law</surname><given-names>S</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Preventive effect of curcumin against chemotherapy-induced
side-effects</article-title>. <source>Front Pharmacol</source>.
<year>2018</year>;<volume>9</volume>:<fpage>1374</fpage>.<pub-id pub-id-type="pmid">30538634</pub-id></mixed-citation></ref><ref id="CIT0016"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guebre-Egziabher</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Alix</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Koppe</surname><given-names>L</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Ectopic lipid accumulation: a potential cause for metabolic disturbances
and a contributor to the alteration of kidney function</article-title>.
<source>Biochimie</source>.
<year>2013</year>;<volume>95</volume>(<issue>11</issue>):<fpage>1971</fpage>&#x02013;<lpage>1979</lpage>.<pub-id pub-id-type="pmid">23896376</pub-id></mixed-citation></ref><ref id="CIT0017"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gundersen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bagger</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Bendtsen</surname><given-names>T</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>The new stereological tools: disector, fractionator, nucleator and point
sampled intercepts and their use in pathological research and diagnosis</article-title>.
<source>APMIS</source>.
<year>1988</year>;<volume>96</volume>(<issue>10</issue>):<fpage>857</fpage>&#x02013;<lpage>881</lpage>.<pub-id pub-id-type="pmid">3056461</pub-id></mixed-citation></ref><ref id="CIT0018"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nyengaard</surname><given-names>JR.</given-names></name></person-group>
<article-title>Stereologic methods and their application in kidney
research</article-title>. <source>J Am Soc Nephrol</source>.
<year>1999</year>;<volume>10</volume>(<issue>5</issue>):<fpage>1100</fpage>&#x02013;<lpage>1123</lpage>.<pub-id pub-id-type="pmid">10232698</pub-id></mixed-citation></ref><ref id="CIT0019"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shanmugam</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Rane</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Kanchi</surname><given-names>MM</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>The multifaceted role of curcumin in cancer prevention and
treatment</article-title>. <source>Molecules</source>.
<year>2015</year>;<volume>20</volume>(<issue>2</issue>):<fpage>2728</fpage>&#x02013;<lpage>2769</lpage>.<pub-id pub-id-type="pmid">25665066</pub-id></mixed-citation></ref><ref id="CIT0020"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noorafshan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ashkani-Esfahani</surname><given-names>S.</given-names></name></person-group>
<article-title>A review of therapeutic effects of curcumin</article-title>. <source>Curr
Pharm Des</source>.
<year>2013</year>;<volume>19</volume>(<issue>11</issue>):<fpage>2032</fpage>&#x02013;<lpage>2046</lpage>.<pub-id pub-id-type="pmid">23116311</pub-id></mixed-citation></ref><ref id="CIT0021"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ugur</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ulu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Dogukan</surname><given-names>A</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>The renoprotective effect of curcumin in cisplatin-induced
nephrotoxicity</article-title>. <source>Ren Fail</source>.
<year>2015</year>;<volume>37</volume>(<issue>2</issue>):<fpage>332</fpage>&#x02013;<lpage>336</lpage>.</mixed-citation></ref><ref id="CIT0022"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Topcu-Tarladacalisir</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sapmaz-Metin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Karaca</surname><given-names>T.</given-names></name></person-group>
<article-title>Curcumin counteracts cisplatin-induced nephrotoxicity by preventing renal
tubular cell apoptosis</article-title>. <source>Ren Fail</source>.
<year>2016</year>;<volume>38</volume>(<issue>10</issue>):<fpage>1741</fpage>&#x02013;<lpage>1748</lpage>.<pub-id pub-id-type="pmid">27758164</pub-id></mixed-citation></ref><ref id="CIT0023"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuhlmann</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Burkhardt</surname><given-names>G</given-names></name>, <name name-style="western"><surname>K&#x000f6;hler</surname><given-names>H.</given-names></name></person-group>
<article-title>Insights into potential cellular mechanisms of cisplatin nephrotoxicity and
their clinical application</article-title>. <source>Nephrol Dial Transplant</source>.
<year>1997</year>;<volume>12</volume>(<issue>12</issue>):<fpage>2478</fpage>&#x02013;<lpage>2480</lpage>.<pub-id pub-id-type="pmid">9430835</pub-id></mixed-citation></ref><ref id="CIT0024"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Lippard</surname><given-names>SJ.</given-names></name></person-group>
<article-title>Cellular processing of platinum anticancer drugs</article-title>.
<source>Nat Rev Drug Discov</source>.
<year>2005</year>;<volume>4</volume>(<issue>4</issue>):<fpage>307</fpage>&#x02013;<lpage>320</lpage>.<pub-id pub-id-type="pmid">15789122</pub-id></mixed-citation></ref><ref id="CIT0025"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Waseem</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kaushik</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Parvez</surname><given-names>S.</given-names></name></person-group>
<article-title>Mitochondria-mediated mitigatory role of curcumin in cisplatin-induced
nephrotoxicity</article-title>. <source>Cell Biochem Funct</source>.
<year>2013</year>;<volume>31</volume>(<issue>8</issue>):<fpage>678</fpage>&#x02013;<lpage>684</lpage>.<pub-id pub-id-type="pmid">23408677</pub-id></mixed-citation></ref><ref id="CIT0026"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name></person-group>
<article-title>Effects of curcumin on the epithelial mesenchymal transition and
TGF-beta/Smads signaling pathway in unilateral ureteral obstruction
rats</article-title>. <source>Zhongguo Zhong Xi Yi Jie He Za Zhi</source>.
<year>2011</year>;<volume>31</volume>(<issue>9</issue>):<fpage>1224</fpage>&#x02013;<lpage>1228</lpage>.<pub-id pub-id-type="pmid">22013801</pub-id></mixed-citation></ref><ref id="CIT0027"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeRubertis</surname><given-names>FR</given-names></name>, <name name-style="western"><surname>Craven</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Melhem</surname><given-names>MF</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Attenuation of renal injury in db/db mice overexpressing superoxide
dismutase: evidence for reduced superoxide-nitric oxide interaction</article-title>.
<source>Diabetes</source>.
<year>2004</year>;<volume>53</volume>(<issue>3</issue>):<fpage>762</fpage>&#x02013;<lpage>768</lpage>.<pub-id pub-id-type="pmid">14988262</pub-id></mixed-citation></ref><ref id="CIT0028"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>BH</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>R</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Protective effects of curcumin on renal oxidative stress and lipid
metabolism in a rat model of type 2 diabetic nephropathy</article-title>. <source>Yonsei
Med J</source>.
<year>2016</year>;<volume>57</volume>(<issue>3</issue>):<fpage>664</fpage>&#x02013;<lpage>673</lpage>.<pub-id pub-id-type="pmid">26996567</pub-id></mixed-citation></ref><ref id="CIT0029"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yousef</surname><given-names>MI</given-names></name>, <name name-style="western"><surname>Omar</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>El-Guendi</surname><given-names>MI</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Potential protective effects of quercetin and curcumin on
paracetamol-induced histological changes, oxidative stress, impaired liver and kidney
functions and haematotoxicity in rat</article-title>. <source>Food Chem
Toxicol</source>.
<year>2010</year>;<volume>48</volume>(<issue>11</issue>):<fpage>3246</fpage>&#x02013;<lpage>3261</lpage>.<pub-id pub-id-type="pmid">20804811</pub-id></mixed-citation></ref><ref id="CIT0030"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Q-M</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X-F</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X-J</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Curcumin improves MMC-based chemotherapy by simultaneously sensitising
cancer cells to MMC and reducing MMC-associated side-effects</article-title>.
<source>Eur J Cancer</source>.
<year>2011</year>;<volume>47</volume>(<issue>14</issue>):<fpage>2240</fpage>&#x02013;<lpage>2247</lpage>.<pub-id pub-id-type="pmid">21616659</pub-id></mixed-citation></ref></ref-list></back></article>